Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$916K Buy
7,752
+763
+11% +$94.4K 0.1% 98
2025
Q4
$879K Sell
6,989
-6,184
-47% -$807K 0.09% 97
2025
Q3
$1.93M Sell
13,173
-325
-2% -$49.1K 0.21% 79
2025
Q2
$2.11M Buy
13,498
+525
+4% +$83.2K 0.24% 73
2025
Q1
$2.14M Buy
12,973
+216
+2% +$35.9K 0.25% 75
2024
Q4
$2.08M Buy
12,757
+450
+4% +$80.5K 0.23% 73
2024
Q3
$2.4M Buy
12,307
+245
+2% +$45.1K 0.27% 70
2024
Q2
$2.09M Buy
12,062
+2,811
+30% +$468K 0.24% 71
2024
Q1
$1.57M Buy
9,251
+3,265
+55% +$612K 0.18% 85
2023
Q4
$1.18M Buy
5,986
+837
+16% +$148K 0.15% 88
2023
Q3
$896K Buy
5,149
+35
+0.7% +$6.36K 0.12% 90
2023
Q2
$881K Buy
5,114
+1,810
+55% +$313K 0.12% 93
2023
Q1
$550K Buy
3,304
+485
+17% +$79.5K 0.08% 101
2022
Q4
$413K Buy
+2,819
New +$417K 0.06% 118

Other funds holding ZTS

Middleton & Co's ZTS Position: Q1 2026 in Review

Middleton & Co increased its Zoetis (ZTS) stake by 11% in Q1 2026, buying an estimated $94.4K and bringing the position to 7,752 shares worth $916K. The position accounts for 0.1% of the portfolio, ranked #98.

Middleton & Co first reported a position in ZTS in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.4M in Q3 2024. 1,606 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Middleton & Co held 7,752 shares of Zoetis worth $916K as of Q1 2026.
  • Middleton & Co bought 763 Zoetis shares in Q1 2026, an estimated $94.4K.
  • Zoetis made up 0.1% of Middleton & Co's portfolio in Q1 2026, its #98 holding.
  • Middleton & Co first reported a position in Zoetis in Q4 2022 and has held it in 14 quarters since.
  • Middleton & Co's Zoetis position peaked at $2.4M in Q3 2024.
  • 1,606 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Middleton & Co's 13F filing for Q1 2026, filed 8 May 2026.